Variant report
Variant | esv3368633 |
---|---|
Chromosome Location | chr1:150752678-150755926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | NR2F2 | chr1:150754593-150754972 | K562 | blood: | n/a | n/a |
2 | PAX5 | chr1:150753464-150753644 | GM12878 | blood: | n/a | n/a |
3 | PAX5 | chr1:150753444-150753640 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr1:150755281-150755324 | MCF-7 | breast: | n/a | n/a |
5 | POLR2A | chr1:150755258-150755275 | MCF-7 | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:150753935..150755523-chr1:150760046..150761556,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SETDB1-7 | chr1:150752748-150753120 | NONHSAT006327 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236713 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs587722064 | chr1:150752687-150752688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs587626022 | chr1:150752750-150752751 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs61817603 | chr1:150752788-150752789 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs376665496 | chr1:150752807-150752808 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs61817604 | chr1:150752814-150752815 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs587653656 | chr1:150752860-150752861 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs15085 | chr1:150752931-150752932 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs80248966 | chr1:150752968-150752969 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs112670510 | chr1:150752982-150752983 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs587745700 | chr1:150753062-150753063 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs587641920 | chr1:150753109-150753110 | Weak transcription Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs202181983 | chr1:150753265-150753266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369842401 | chr1:150753267-150753268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143352084 | chr1:150753303-150753304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376172983 | chr1:150753344-150753345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6676814 | chr1:150753351-150753352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs587688183 | chr1:150753361-150753362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs587763088 | chr1:150753383-150753384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs587650435 | chr1:150753398-150753399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs587701752 | chr1:150753405-150753406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs61817605 | chr1:150753476-150753477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12404949 | chr1:150753487-150753488 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs369617019 | chr1:150753497-150753498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373216609 | chr1:150753509-150753510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs587716399 | chr1:150753551-150753552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34002273 | chr1:150753595-150753596 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs587665581 | chr1:150753605-150753606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs587706443 | chr1:150753686-150753687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs587605695 | chr1:150753757-150753758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201734118 | chr1:150753758-150753759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35250403 | chr1:150753781-150753782 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
32 | rs376288118 | chr1:150753899-150753900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184359544 | chr1:150753910-150753911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61817607 | chr1:150753920-150753921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs61817608 | chr1:150753946-150753947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371026223 | chr1:150753950-150753951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs61817609 | chr1:150753966-150753967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61817610 | chr1:150753981-150753982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61817631 | chr1:150753986-150753987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186801796 | chr1:150753990-150753991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs587668105 | chr1:150754017-150754018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201063551 | chr1:150754030-150754031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs587768407 | chr1:150754110-150754111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374626744 | chr1:150754136-150754137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs587643774 | chr1:150754146-150754147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs587696722 | chr1:150754218-150754219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs587754276 | chr1:150754263-150754264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs587652029 | chr1:150754275-150754276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377273164 | chr1:150754280-150754281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs587683390 | chr1:150754342-150754343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21611746 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Cancer | 23975201 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:150737200-150761800 | Weak transcription | Spleen | Spleen |
2 | chr1:150744600-150768200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr1:150746800-150753400 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr1:150750600-150753400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr1:150750600-150767600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr1:150751200-150752800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr1:150752800-150753200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
8 | chr1:150752800-150753600 | Weak transcription | Colonic Mucosa | Colon |
9 | chr1:150753200-150753400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr1:150753400-150755200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
11 | chr1:150753400-150755200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
12 | chr1:150754800-150759400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr1:150755000-150755600 | Enhancers | Ovary | ovary |
14 | chr1:150755000-150755600 | Enhancers | K562 | blood |
15 | chr1:150755200-150755600 | Enhancers | Primary monocytes fromperipheralblood | blood |
16 | chr1:150755200-150755600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr1:150755400-150755600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr1:150755400-150756200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr1:150755600-150756200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr1:150755600-150756400 | Weak transcription | Ovary | ovary |
21 | chr1:150755600-150757000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
22 | chr1:150755600-150758000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
23 | chr1:150755600-150760000 | Weak transcription | K562 | blood |